Clinical Trial Record

Return to Clinical Trials

A Study in Postoperative Pancreatic Fistula


2018-05-01


2020-05-01


2020-05-01


300

Study Overview

A Study in Postoperative Pancreatic Fistula

The International Study Group of Pancreatic Surgery (ISGPS) issued the definition and classification system of postoperative pancreatic fistula (POPF), and received widespread recognition. Currently, it has become an important reference for clinical treatment of POPF.

The definition of POPF released by ISGPS in 2016 still seems to have certain deficiency. For example, in both definitions in 2005 and 2016, the re-operation is used as an important judgment index of "Grade C POPF". But a unified standard or consensus is still lacked for the indication of POPF re-operation, which may finally impact the diagnosis of "Grade C POPF". Therefore, we performed this study, so as to better improve the relevant definition and provide guidance for the diagnosis and treatment.

  • Pancreatic Cancer
    • SAHZhejiangU06

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2017-04-04  

    N/A  

    2017-10-05  

    2017-04-23  

    N/A  

    2017-10-09  

    2017-04-26  

    N/A  

    2017-04  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    : POPF group

    Patients who had POPF will be included into POPF group.

    : Observation group

    Patients without POPF will be included into observation group.

    Primary Outcome MeasuresMeasure DescriptionTime Frame
    Pancreatic fistulaThe determine of pancreatic fistula follows the International Study Group on Pancreatic Fistulas (ISGPF) criteriaFrom date of operation until the date of in-hospital death or death within 30 days after operation, whichever came first, assessed up to 200 days
    Secondary Outcome MeasuresMeasure DescriptionTime Frame
    Hospital staysPost-operation hospital stay is assessedFrom date of operation until the date of in-hospital death or death within 30 days after operation, whichever came first, assessed up to 200 days
    Number of hospitalizationsNumber of hospitalizations during the observational periodFrom date of operation until the date of in-hospital death or death within 30 days after operation, whichever came first, assessed up to 200 days
    MortalityPostoperative death in 30 days are considered concerned with pancreatic fistulaFrom date of operation until the date of in-hospital death or death within 30 days after operation, whichever came first, assessed up to 200 days

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Study Contact

    Name: Xue-Li Bai, phD

    Phone Number: +86 571 87783510

    Email: shirleybai57@hotmail.com

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    18 Years

    Accepts Healthy Volunteers:

      Inclusion Criteria:

    • Must have a diagnosis of POPF;
    • Aged 18 or older;
    • Of either sex.

    • Exclusion Criteria:

    • No specific exclusion criteria will be applied to a participant as long as the participant is eligible for the trial.

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.


      • STUDY_CHAIR: Ting-Bo Liang, phD, Second Affiliated Hospital of Zhejiang University School of Medicine

      Publications

      The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

      General Publications

      No publications available